A Novel PAA Derivative with Enhanced Drug Efficacy in Pancreatic Cancer Cell Lines

Nanoparticles have been shown to be effective drug carriers in cancer therapy. Pancreatic cancer forms dense tumours which are often resistant to drug molecules. In order to overcome such multidrug resistance, new drug entities, novel delivery systems and combination therapy strategies are being exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Alsuraifi, Ali, Lin, Paul Kong Thoo, Curtis, Anthony, Lamprou, Dimitrios A., Hoskins, Clare
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315666/
https://www.ncbi.nlm.nih.gov/pubmed/30248980
http://dx.doi.org/10.3390/ph11040091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315666/
https://www.ncbi.nlm.nih.gov/pubmed/30248980
http://dx.doi.org/10.3390/ph11040091

Ejemplares similares